Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017

S. Yadgir, C.O. Johnson, V. Aboyans, O.M. Adebayo, R.A. Adedoyin, M. Afarideh, F. Alahdab, A. Alashi, V. Alipour, J. Arabloo, S. Azari, C.M. Barthelemy, C.P. Benziger, A.E. Berman, A. Bijani, J.J. Carrero, F. Carvalho, A. Daryani, A.R. Durães, A. Esteghamati, T.A. Farid, F. Farzadfar, E. Fernandes, I. Filip, M.M. Gad, S. Hamidi, S.I. Hay, O.S. Ilesanmi, S.S.N. Irvani, M. Jürisson, A. Kasaeian, A.P. Kengne, A.R. Khan, A. Kisa, S. Kisa, D. Kolte, N. Manafi, A. Manafi, G.A. Mensah, E.M. Mirrakhimov, Y. Mohammad, A.H. Mokdad, R.I. Negoi, H.L.T. Nguyen, T.H. Nguyen, M.R. Nixon, C.M. Otto, S. Patel, T. Pilgrim, A. Radfar, D.L. Rawaf, S. Rawaf, W.F. Rawasia, A. Rezapour, L. Roever, A.M. Saad, S. Saadatagah, S. Senthilkumaran, K. Sliwa, B.E. Tesfay, B.X. Tran, I. Ullah, M. Vaduganathan, T.J. Vasankari, C.D. Wolfe, N. Yonemoto, G.A. Roth
2020-03-29
Abstract:Background Nonrheumatic valvular diseases are common; however, no studies have estimated their global or national burden. As part of the Global Burden of Disease Study 2017, mortality, prevalence, and disability-adjusted life-years (DALYs) for calcific aortic valve disease (CAVD), degenerative mitral valve disease, and other nonrheumatic valvular diseases were estimated for 195 countries and territories from 1990 to 2017. Methods Vital registration data, epidemiologic survey data, and administrative hospital data were used to estimate disease burden using the Global Burden of Disease Study modeling framework, which ensures comparability across locations. Geospatial statistical methods were used to estimate disease for all countries, because data on nonrheumatic valvular diseases are extremely limited for some regions of the world, such as Sub-Saharan Africa and South Asia. Results accounted for …
What problem does this paper attempt to address?